• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐匿性导管破裂在接受依前列醇治疗的患者中引起发作性症状。

Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol.

作者信息

LeVarge Barbara L, Law Anica C, Murphy Blanche

机构信息

1 6797 Pulmonary Diseases and Critical Care Medicine, University of North Carolina , Chapel Hill, NC, USA.

2 Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.

出版信息

Pulm Circ. 2018 Jan-Mar;8(1):2045893217748054. doi: 10.1177/2045893217748054.

DOI:10.1177/2045893217748054
PMID:29249170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5753954/
Abstract

Infection, thrombosis, and catheter dislodgment are well-recognized potential complications of chronic intravenous prostanoid therapy for pulmonary arterial hypertension. As long-term outcomes of pulmonary hypertension patients improve, novel adverse events are likely to arise. We describe the sudden development of unexplained hypotension and lightheadedness in a patient receiving intravenous epoprostenol for several years, ultimately determined to be due to an unusual catheter complication, not previously described in this population.

摘要

感染、血栓形成和导管移位是公认的慢性静脉注射前列环素治疗肺动脉高压的潜在并发症。随着肺动脉高压患者长期预后的改善,可能会出现新的不良事件。我们描述了一名接受静脉注射依前列醇数年的患者突然出现原因不明的低血压和头晕,最终确定是由于一种不寻常的导管并发症所致,该并发症在该人群中此前未曾有过描述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bc/5753954/45352c9365fc/10.1177_2045893217748054-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bc/5753954/45352c9365fc/10.1177_2045893217748054-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17bc/5753954/45352c9365fc/10.1177_2045893217748054-fig1.jpg

相似文献

1
Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol.隐匿性导管破裂在接受依前列醇治疗的患者中引起发作性症状。
Pulm Circ. 2018 Jan-Mar;8(1):2045893217748054. doi: 10.1177/2045893217748054.
2
Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.具有保护连接的封闭枢纽系统与接受静脉注射前列环素治疗肺动脉高压的儿科患者导管相关血流感染风险的降低
Infect Control Hosp Epidemiol. 2009 Sep;30(9):823-9. doi: 10.1086/605320.
3
Complications associated with peripherally inserted central catheters and Hickman™ in patients with advanced pulmonary hypertension treated with intravenous prostanoids.静脉应用前列环素类药物治疗的晚期肺动脉高压患者中,与经外周插入的中心静脉导管和 Hickman 导管相关的并发症。
Respir Med. 2021 Nov-Dec;189:106649. doi: 10.1016/j.rmed.2021.106649. Epub 2021 Oct 19.
4
[Transition from intravenous to subcutaneous prostacyclin in pulmonary hypertension].[肺动脉高压患者从静脉注射前列环素转换为皮下注射前列环素的研究]
Rev Esp Cardiol. 2003 Aug;56(8):818-21. doi: 10.1016/s0300-8932(03)76962-0.
5
Advances in prostanoid infusion therapy for pulmonary arterial hypertension.肺动脉高压的前列环素输注疗法进展
J Infus Nurs. 2008 Nov-Dec;31(6):336-45. doi: 10.1097/NAN.0b013e31818c09b1.
6
Incidence of Bloodstream Infection in Patients with Pulmonary Hypertension under Intravenous Epoprostenol or Iloprost-A Multicentre, Retrospective Study.静脉应用依前列醇或伊洛前列素治疗的肺动脉高压患者血流感染发生率:一项多中心回顾性研究。
Int J Mol Sci. 2023 Mar 29;24(7):6434. doi: 10.3390/ijms24076434.
7
Epoprostenol Therapy for Pulmonary Arterial Hypertension.依前列醇治疗肺动脉高压
Acta Med Okayama. 2015;69(3):129-36. doi: 10.18926/AMO/53519.
8
Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri): a prospective, 6-months, open label, observational, non-interventional study.静脉注射依前列醇(Veletri)治疗重度肺动脉高压患者的耐受性、安全性和生存情况:一项前瞻性、6 个月、开放标签、观察性、非干预性研究。
Respir Res. 2023 Jan 18;24(1):18. doi: 10.1186/s12931-022-02296-z.
9
Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center.一家中心对结缔组织病合并肺动脉高压患者采用静脉内依前列醇治疗。
Mod Rheumatol. 2013 Nov;23(6):1211-20. doi: 10.1007/s10165-012-0828-1. Epub 2013 Jan 29.
10
The role of treprostinil in the management of pulmonary hypertension.曲前列尼尔在肺动脉高压管理中的作用。
Am J Cardiovasc Drugs. 2008;8(4):213-7. doi: 10.2165/00129784-200808040-00001.

本文引用的文献

1
The "bouncing" catheter.“弹跳式”导管。
Cardiol J. 2016;23(5):552-553. doi: 10.5603/CJ.2016.0076.
2
Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.用于前臂植入式中心静脉导管装置的聚氨酯导管与硅胶导管的比较
Eur J Cancer. 2016 May;59:113-124. doi: 10.1016/j.ejca.2016.02.011. Epub 2016 Mar 26.
3
A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients.预防中心静脉导管并发症的综合方法:儿科血液肿瘤患者10年前瞻性监测结果
Ann Hematol. 2016 Apr;95(5):817-25. doi: 10.1007/s00277-016-2634-x. Epub 2016 Mar 10.
4
Damage of Central Catheters in Home Parenteral Nutrition Patients.家庭肠外营养患者中心静脉导管的损伤
Pol Przegl Chir. 2015 Nov;87(11):579-86. doi: 10.1515/pjs-2016-0006.
5
A comparison of silicone and polyurethane PICC lines and postinsertion complication rates: a systematic review.硅胶和聚氨酯经外周静脉穿刺中心静脉置管(PICC)导管的比较及置管后并发症发生率:一项系统评价
J Vasc Access. 2015 May-Jun;16(3):167-77. doi: 10.5301/jva.5000330. Epub 2015 Jan 23.
6
Long-term survival of patients with pulmonary arterial hypertension recovering to World Health Organization functional class I or II: a historical comparison between intravenous epoprostenol and oral agents.恢复至世界卫生组织功能分级I级或II级的肺动脉高压患者的长期生存:静脉用依前列醇与口服药物的历史比较
BMC Res Notes. 2014 Jun 12;7:359. doi: 10.1186/1756-0500-7-359.
7
Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days.癌症患者家庭肠外营养相关导管并发症:超过 51000 天导管日的前瞻性研究。
JPEN J Parenter Enteral Nutr. 2013 May-Jun;37(3):375-83. doi: 10.1177/0148607112460552. Epub 2012 Sep 20.
8
Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®.静脉前列环素治疗肺动脉高压患者的血流感染:来自 REVEAL 登记研究的观察。
Mayo Clin Proc. 2012 Sep;87(9):825-34. doi: 10.1016/j.mayocp.2012.05.014. Epub 2012 Aug 9.
9
Low incidence of catheter-related complications in patients with advanced pulmonary arterial hypertension undergoing continuous epoprostenol infusion.接受依前列醇持续输注的晚期肺动脉高压患者导管相关并发症的发生率较低。
Chest. 2012 Jan;141(1):272-273. doi: 10.1378/chest.11-1893.
10
Renal Association Clinical Practice Guideline on vascular access for haemodialysis.肾脏协会血液透析血管通路临床实践指南。
Nephron Clin Pract. 2011;118 Suppl 1:c225-40. doi: 10.1159/000328071. Epub 2011 May 6.